Neuregulin1 (NRG1) Signaling through Fyn Modulates NMDA Receptor Phosphorylation: Differential Synaptic Function in NRG1+/− Knock-Outs Compared with Wild-Type Mice

作者: M. Bjarnadottir , D. L. Misner , S. Haverfield-Gross , S. Bruun , V. G. Helgason

DOI: 10.1523/JNEUROSCI.4314-06.2007

关键词: NMDA receptorTyrosine kinasePhosphorylationSynaptic plasticityTyrosine kinase 2ERBB4BiologyFYNCancer researchReceptor tyrosine kinaseCell biology

摘要: We previously identified Neuregulin1 ( NRG1 ) as a gene contributing to the risk of developing schizophrenia. Furthermore, we showed that +/− mutant mice display behavioral abnormalities are reversed by clozapine, an atypical antipsychotic drug used for treatment now present evidence ErbB4 (v-erb-a erythroblastic leukemia viral oncogene homolog 4), tyrosine kinase receptor in hippocampal neurons, interacts with two nonreceptor kinases, Fyn and Pyk2 (proline-rich 2). stimulation cells expressing leads association consequent activation. show signaling, through activation stimulates phosphorylation Y1472 on NR2B subunit NMDA (NMDAR), key regulatory site modulates channel properties. is hypophosphorylated mice, this defect can be clozapine at dose reverses their abnormalities. also demonstrate short-term synaptic plasticity altered theta-burst long-term potentiation impaired incubation slices from these those effects. Attenuated signaling may contribute pathophysiology schizophrenia dysfunction NMDAR modulation. Thus, our data support glutamate hypothesis

参考文章(50)
Robert Gerlai, Paul Pisacane, Sharon Erickson, Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. Behavioural Brain Research. ,vol. 109, pp. 219- 227 ,(2000) , 10.1016/S0166-4328(99)00175-8
P J Harrison, D R Weinberger, Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry. ,vol. 10, pp. 40- 68 ,(2005) , 10.1038/SJ.MP.4001558
Ivan Dikic, George Tokiwa, Sima Lev, Sara A Courtneidge, Joseph Schlessinger, None, A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation Nature. ,vol. 383, pp. 547- 550 ,(1996) , 10.1038/383547A0
Kenneth A. Pelkey, Rand Askalan, Surojit Paul, Lorraine V. Kalia, Tri-Hung Nguyen, Graham M. Pitcher, Michael W. Salter, Paul J. Lombroso, Tyrosine Phosphatase STEP Is a Tonic Brake on Induction of Long-Term Potentiation Neuron. ,vol. 34, pp. 127- 138 ,(2002) , 10.1016/S0896-6273(02)00633-5
Surojit Paul, Angus C. Nairn, Ping Wang, Paul J. Lombroso, NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nature Neuroscience. ,vol. 6, pp. 34- 42 ,(2003) , 10.1038/NN989
S. Grant, T. O'Dell, K. Karl, P. Stein, P Soriano, E. Kandel, Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science. ,vol. 258, pp. 1903- 1910 ,(1992) , 10.1126/SCIENCE.1361685
Nadine Norton, Valentina Moskvina, Derek W Morris, Nicholas J Bray, Stanley Zammit, Nigel M Williams, Hywel J Williams, Anna C Preece, Sarah Dwyer, Jennifer C Wilkinson, Gillian Spurlock, George Kirov, Paul Buckland, John L Waddington, Michael Gill, Aiden P Corvin, Michael J Owen, Michael C O'Donovan, None, Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. American Journal of Medical Genetics. ,vol. 141, pp. 96- 101 ,(2006) , 10.1002/AJMG.B.30236
Y. Hakak, J. R. Walker, C. Li, W. H. Wong, K. L. Davis, J. D. Buxbaum, V. Haroutunian, A. A. Fienberg, Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 4746- 4751 ,(2001) , 10.1073/PNAS.081071198
R Hashimoto, R E Straub, C S Weickert, T M Hyde, J E Kleinman, D R Weinberger, Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Molecular Psychiatry. ,vol. 9, pp. 299- 307 ,(2004) , 10.1038/SJ.MP.4001434